Business Investment Opportunities in Gurgaon - Invest in a Business in Gurgaon

130+ Business Investment Opportunities in Gurgaon as on January 2019. Invest in a Business in Gurgaon and 150 countries, 950+ Industries, with profit margins up to 60% investment ranging from INR 2.1 lakh - 210 crore. Explore pre-screened Business Investment Opportunities in Gurgaon with verified contact details, valuation details and business photographs. Join our 647,000+ member network to Invest in a Business in Gurgaon. Create a Business profile to Finance your Business in Gurgaon.

Filters
  • Gurgaon

  • Investment Opportunities

  • businesses for sale in hyderabad

Internet Business Investment Opportunity in Gurgaon, India

New Delhi based start-up working on an innovative platform for automating & simplifying business processes.
► Registered as a Limited Liability Partnership ( LLP ) in Gurgaon ( adjoining New Delhi, India, we are a student run start-up based at New Delhi with operations support teams based at Gurgaon, New Delhi and Warangal. We are working towards creating an end-to-end one-stop online and mobile platform to help businesses grow by automating their business processes; essentially working as a technology-based incubator and advisory firm for small and medium businesses in early & growth stage. ► There are 48 million Small and Medium Enterprises ( SMEs ) in India, second largest number in world after China ( 50 Million. These SMEs provide employment to 40% of India’s workforce, produce 45% of nation’s manufacturing output and contribute to 22% of GDP. 1.5 Million of these SMEs export products / services outside India. SMEs have seen a tremendous growth over last few years, notably in sectors like manufacturing, pharmaceuticals, food processing, service sectors, agro, retail, IT, textile & garments to name a few. However, there exists a huge gap between the professionalism evident in the functioning of large national and multi-national corporations and the highly unorganized SME sector. ► We as a group of young, energetic, innovative & dynamic individuals are trying to bridge this gap. Looking at it as an opportunity, we intend to make optimal use of technical tools, to automate functions like strategic business analysis, profiling and networking, real-time logistics and supply chain management & financial analysis / optimization; helping business owners and management discover and connect to strategically important B2B consumers / suppliers, co-relate their business with macro-market statistics and insights, formulate business strategy accordingly, thence mitigating external factors, lowering risk & maximizing revenue. ► The product launch is scheduled in first week of November, 2015, after one month of in-house beta testing. ► The management team consists of academically proficient and hard-working business undergraduates and MBA students. The technical team is made up of students from IIT ( Indian Institute of Technology, Delhi and NIT ( National Institute of Technology, Warangal.
7.2   Gurgaon
Run Rate Sales
USD 14 thousand
EBITDA Margin
20 - 30 %
Financial Investment
USD 28 thousand for 40% stake
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Gurgaon, India

Cancer immunotherapy based research & medicine manufacturing company based out of Gurgaon.
- Business came into existence in the year 2010 with a vision to find the roots of cancer and to improve the quality of life by immunology based Dendritic cell-based therapy. - Company aims to provide an economical and effective method of DC immunotherapy in India. - We received the Indian FDA approval to manufacture / market immunotherapy treatment-related medicines for cancer in India in Dec 2017. We started selling medicines from April 2018. - Tie-ups with various hospitals, oncologists and Government health schemes for the supply of products in Delhi NCR region. - We prepare custom-made medicine for each & every patient. So the production number depends upon the requirements from customers. - Company launched Phase II clinical trials across 7 hospitals in India where it treated 51 patients. - We have the capacity to treat 600 patients on an annual basis. The company was conferred with the Excellence award for DC clinical trial at UAE Cancer Congress at Dubai. - Company would start making profits in the near future. Last our sales was only from the research work. This year sale of medicines too helped in revenue generation. We will continue to see this improving. - Promoter1: A visionary entrepreneur, responsible for developing dendritic cell immunotherapy at a commercial scale in India. - Promoter2: A first generation entrepreneur responsible for bringing the cellular therapies in India.
8.0   Gurgaon
Run Rate Sales
USD 250 thousand
EBITDA Margin
20 - 30 %
Financial Investment
USD 17 million for 26% stake
Contact Business
Need help?